SHOW

Dr Hale did his graduate studies studying oral streptococci under the supervision of Professor John Tagg at the Department of Microbiology and Immunology, University of Otago, New Zealand. In this work, he identified and characterised bacterial anti-competitor molecules known as bacteriocin’s. Following this, he carried out post-doctoral research at the University of British Columbia (Vancouver, Canada) characterising the mode of action of these molecules and as a Research Fellow at Monash University School of Pharmacy (Melbourne, Australia) investigating the modes of resistance of antimicrobial peptides. Dr Hale joined BLIS Technologies in 2011 and is the Chief Technology Officer. He also holds an adjunct Senior Lecturer position with the Department of Microbiology and Immunology, University of Otago, New Zealand.